Literature DB >> 18032500

Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein.

Timothy L Tellinghuisen1, Katie L Foss, Jason C Treadaway, Charles M Rice.   

Abstract

The NS5A protein of hepatitis C virus (HCV) plays an important but undefined role in viral RNA replication. NS5A has been proposed to be a three-domain protein, and the crystal structure of the well-conserved amino-terminal domain I has been determined. The remaining two domains of NS5A, designated domains II and III, and their corresponding interdomain regions are poorly understood. We have conducted a detailed mutagenesis analysis of NS5A domains II and III using the genotype 1b HCV replicon system. The majority of the mutants containing 15 small (8- to 15-amino-acid) deletions analyzed were capable of efficient RNA replication. Only five deletion mutations yielded lethal phenotypes, and these were colinear, spanning a 56-amino-acid region within domain II. This region was further analyzed by combining triple and single alanine scanning mutagenesis to identify individual residues required for RNA replication. Based upon this analysis, 23 amino acids were identified that were found to be essential. In addition, two residues were identified that yielded a small colony phenotype while possessing only a moderate defect in RNA replication. These results indicate that the entire domain III region and large portions of domain II of the NS5A protein are not required for the function of NS5A in HCV RNA replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032500      PMCID: PMC2224455          DOI: 10.1128/JVI.00328-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Hepatitis C: global prevalence.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1997-11-14

2.  Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome.

Authors:  D B Smith; P Simmonds
Journal:  J Mol Evol       Date:  1997-09       Impact factor: 2.395

3.  Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA.

Authors:  Julie K Pfeiffer; Karla Kirkegaard
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Viral and cellular determinants of hepatitis C virus RNA replication in cell culture.

Authors:  Volker Lohmann; Sandra Hoffmann; Ulrike Herian; Francois Penin; Ralf Bartenschlager
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus.

Authors:  M Hijikata; H Mizushima; T Akagi; S Mori; N Kakiuchi; N Kato; T Tanaka; K Kimura; K Shimotohno
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

6.  Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites.

Authors:  A Grakoui; D W McCourt; C Wychowski; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

7.  The NS5A protein of hepatitis C virus is a zinc metalloprotein.

Authors:  Timothy L Tellinghuisen; Joseph Marcotrigiano; Alexander E Gorbalenya; Charles M Rice
Journal:  J Biol Chem       Date:  2004-08-31       Impact factor: 5.157

8.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

9.  Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase.

Authors:  Timothy L Tellinghuisen; Joseph Marcotrigiano; Charles M Rice
Journal:  Nature       Date:  2005-05-19       Impact factor: 49.962

10.  Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication.

Authors:  Shuanghu Liu; Israrul H Ansari; Subash C Das; Asit K Pattnaik
Journal:  J Gen Virol       Date:  2006-02       Impact factor: 3.891

View more
  105 in total

Review 1.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  A genetic interaction between the core and NS3 proteins of hepatitis C virus is essential for production of infectious virus.

Authors:  Daniel M Jones; Ali M Atoom; Xiaozhen Zhang; Shyamasundaran Kottilil; Rodney S Russell
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.

Authors:  Shuanghu Liu; Cassie A Nelson; Li Xiao; Ling Lu; Punit P Seth; Darrell R Davis; Curt H Hagedorn
Journal:  Antiviral Res       Date:  2010-11-12       Impact factor: 5.970

4.  Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A.

Authors:  Jill Walker; Renae Crosby; Amy Wang; Ermias Woldu; Jessica Vamathevan; Christian Voitenleitner; Shihyun You; Katja Remlinger; Maoshang Duan; Wieslaw Kazmierski; Robert Hamatake
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

5.  The Hepatitis C Virus NS5A Stimulates NS5B During In Vitro RNA Synthesis in a Template Specific Manner.

Authors:  Elizabeth M Quezada; Caroline M Kane
Journal:  Open Biochem J       Date:  2009-04-20

6.  DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A.

Authors:  Lotte Coelmont; Xavier Hanoulle; Udayan Chatterji; Carola Berger; Joke Snoeck; Michael Bobardt; Precious Lim; Inge Vliegen; Jan Paeshuyse; Grégoire Vuagniaux; Anne-Mieke Vandamme; Ralf Bartenschlager; Philippe Gallay; Guy Lippens; Johan Neyts
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

7.  A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach.

Authors:  Feng Yang; Jason M Robotham; Henry Grise; Stephen Frausto; Vanesa Madan; Margarita Zayas; Ralf Bartenschlager; Margaret Robinson; Andrew E Greenstein; Anita Nag; Timothy M Logan; Ewa Bienkiewicz; Hengli Tang
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

8.  Hepatitis C virus NS4B carboxy terminal domain is a membrane binding domain.

Authors:  Jolanda M P Liefhebber; Bernd W Brandt; Rene Broer; Willy J M Spaan; Hans C van Leeuwen
Journal:  Virol J       Date:  2009-05-25       Impact factor: 4.099

9.  A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B.

Authors:  Lucile Warter; Lisette Cohen; Yann Benureau; Deborah Chavez; Yan Yang; Francis Bodola; Stanley M Lemon; Cinzia Traboni; Robert E Lanford; Annette Martin
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

10.  Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A.

Authors:  Fiona Fernandes; Israr-ul H Ansari; Rob Striker
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.